Agrochemicals

Agricultural practices are under huge scrutiny: environmental concerns, issues of sustainability, security and reliability interplay with commercial aspects relating to the cost and the quality of agricultural products, be they plants or livestock. Historically, agrochemicals have featured prominently in the development of new and improved methods of agronomy and animal husbandry. The opportunities within these areas of agriculture are vast, and offer exciting prospects for those working in both the chemical and life sciences fields. Novel technologies proving clear agricultural benefits are deserving of protection, and Mewburn Ellis can provide the bespoke advice and support for those looking to secure a strong commercial position in a frequently highly competitive area.

Agrochemicals are wide-ranging in their use, their activity and fundamentally in their structures also. Mewburn Ellis can provide a strength and depth of intellectual property experience that is unrivalled, and is well matched to the challenges in this technology. We have a strong, personal interest in animal and plant health and the environmental benefits that arise from a close control of pests and diseases, closely aligned with biosafety concerns. Many agricultural technology firms now place environmental protection at the forefront of their research work and this aligns with our own values and ethos, and we are proud to work for clients who promote and develop sustainably agriculture around the world.

We can provide the critical assessment of the experiments that support the latest agrochemical innovations, and we appreciate the difficulties in obtaining data from complex biological models and extensive field trials. Indeed, we are also regularly work with our clients to design those experiments and to select comparisons that will show an invention to its greatest advantage. We look to exploit good data, and use it as the basis for strong, defendable patents. Our hard work from the very start of the research and development process gives our clients the reward of strong - frequently foundational – intellectual property with clear commercial relevance. Our interest in the larger relevance of the technology to its exploitation also provides us with the opportunity to clear the disrupting obstacles placed by competitors. Our work in opposing competitors’ patents in Europe is highly envied, and we can point to many significant examples where we have severely limited or entirely destroyed the patents of those attempting to limit the work of our clients.

We support innovation, and we are always attracted to agrochemical firms who marry forward thinking research work with a strong social responsibility. We can and will look to support those companies who encourage agronomy and livestock health with environmental sustainability.

Meet our Specialists

OUR PEOPLE
Open pages of Green IP Report

Green IP Report

Patents are both a driver and a barometer of innovation

Our report examines the role of patents in making innovative ‘green’ technologies into a reality as well as how the patent landscape can be used to identify opportunities for partnering, collaboration and investment.

We share our enthusiasm and admiration for commercially-focused innovation across a diverse range of technologies, from repurposing carbon dioxide to make protein-rich foods, to the multi-faceted approach to a circular plastics economy. We also discuss the tantalising prospect of AI-mediated renewable energy supply, and the harnessing of battery tech from the EV boom to drive energy efficiency in consumer devices. This report reflects our passion for technology solutions that tackle our shared global challenge.

Download the Report

Read our Blogs

Thin but Mighty: Innovations in Battery Separators

Thin but Mighty: Innovations in Battery Separators

by Rhys Williams

Innovation in battery technology is continuing at pace. Developments in this field range from broader considerations relating to battery architecture, power supply/distribution and delivery ...

G 1/23 – Redefining when a product can be state of the art

G 1/23 – Redefining when a product can be state of the art

by Andrew Pitts

The Enlarged Board of Appeal (EBA) at the EPO recently handed down the long-expected decision G 1/23 concerning the double “analysable and reproducible” requirement laid down in earlier decision G ...

Most opposed companies at the EPO in 2024

Most opposed companies at the EPO in 2024

by Katherine Green

Opposition activity at the European Patent Office is often a strong indicator of a technology’s commercial relevance. We analysed the companies holding the highest numbers of European patents that ...

Resilient Chemistry – a conversation with Professor Peter Licence

Resilient Chemistry – a conversation with Professor Peter Licence

by Rebecca Blundell

Peter Licence explains how resilient chemistry can ensure the long-term viability of the chemical industry and address global challenges through sustainable and innovative practices.

Mewburn Ellis is proud to have worked on 24 of the 100 top-selling pharmaceuticals of 2024

Mewburn Ellis is proud to have worked on 24 of the 100 top-selling pharmaceuticals of 2024

by Adam Gregory

Mewburn Ellis works with some of the world’s most important pharmaceuticals and biologics across a broad range of therapeutic areas.

Event - Powering the Future: Unlocking the UK’s Battery Potential, 25 June

Event - Powering the Future: Unlocking the UK’s Battery Potential, 25 June

by Callum McGuinn

We were delighted to host a panel discussion and networking event at our new London Office, bringing together experts and professionals from across the battery industry. The evening began with a warm ...

Learn More
Forward Magazines Overlapping 8

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.